Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Vallon Pharmaceuticals, Inc. VLON NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Chart & Stats

Market Data
52-Week Range0.3803-0.4308
Volume1.11M
Beta (1Y)-1.15
IPO Date2021-02-10
Employees2
CEODavid C. Baker
Financial Highlights & Ratios
Analyst Forecast
Rating ConsensusBuy
Analysts Covering1
Buy 100% Hold 0% Sell 0%
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS92023M1018

Price Chart

Track all markets on TradingView
VLON
Vallon Pharmaceuticals, Inc. ↗  ·  NASDAQ Capital Marke
Healthcare • Biotechnology
0.38 52WK RANGE 0.43

People Also View

IMNM
IMNM
Immunome, Inc.
$22.90
+1.24%
 ATNF
ATNF
180 Life Sciences Corp.
$7.04
-7.49%
 IKNA
IKNA
Ikena Oncology, Inc.
$17.16
+1,152.55%
 ZURA
ZURA
Zura Bio Limited
$5.72
+0.70%
 PALI
PALI
Palisade Bio, Inc.
$2.06
+3.52%
 FHTX
FHTX
Foghorn Therapeutics Inc.
$4.85
+3.41%
 UNCY
UNCY
Unicycive Therapeutics, Inc.
$6.94
+4.83%
 CLNN
CLNN
Clene Inc.
$6.68
+3.01%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message